Secondary Chondrosarcoma
J Am Acad Orthop Surg, Vol 18, No 10, October 2010 Patrick P. Lin, MD, Charbel D. Moussallem, MD and Michael T. Deavers, MD Secondary chondrosarcoma is a distinctive type of tumor that originates from a preexisting cartilaginous lesion. Most commonly, it is associated with solitary or multiple osteochondromas. A fraction of cases arises from […]
Pressure Ulcers in Orthopaedics
NULL J Am Acad Orthop Surg, Vol 18, No 9, September 2010 D. «Trey» Remaley, DO and Todd Jaeblon, DO Pressure ulcers can be a devastating complication in the care of orthopaedic patients. Their presence leads to increased morbidity, mortality, and cost of care. Therapy and rehabilitation cannot progress on a normal postoperative course in […]
Perioperative Management of Diabetes and Hyperglycemia in Patients Undergoing Orthopaedic Surgery
NULL Ali A. Rizvi, MD, Shawn A. Chillag, MD and Kim J. Chillag, MD J Am Acad Orthop Surg 2010 18:. Persons with diabetes undergo more surgical procedures, have a higher perioperative risk of complications, and have longer hospital stays than do persons who do not have diabetes. Persons with diabetes are frequently overweight, have […]
Orthopaedic Manifestations of Neurofibromatosis Type 1
NULL David S. Feldman, MD, Charles Jordan, MD and Lauren Fonseca, BA Neurofibromatosis type 1 (NF-1) is an autosomal dominant disease that affects 1 in 3,000 persons worldwide. Café-au-lait macules and peripheral nerve sheath tumors (ie, neurofibromas) are the most commonly recognized manifestations of NF-1. However, NF-1 affects multiple organ systems, and a multidisciplinary approach […]
Osteofibrous Dysplasia and Adamantinoma
J Am Acad Orthop Surg, Vol 18, No 6, June 2010 Mathew J. Most, MD, Franklin H. Sim, MD and Carrie Y. Inwards, MD Osteofibrous dysplasia (OFD) is a rare, benign, fibro-osseous lesion that typically is seen within the cortex of the tibia in children. Adamantinoma (AD) is a rare, low-grade malignant primary bone tumor […]
Perioperative Management of the Patient With Cardiac Disease
NULL J Am Acad Orthop Surg, Vol 18, No 5 Robert C. Decker, MD, Jennifer R. Foley, MD and Thomas J. Moore, MD Dr. Moore or an immediate family member is a member of a speakers bureau or has made paid presentations on behalf of Osteotech and Synthes, serves as an unpaid consultant to Osteotech, […]
Reporting and Notification of Adverse Events in Orthopaedics
J Am Acad Orthop Surg, Vol 18, No 4, April 2010 William M. Mihalko, MD, PhD, A. Seth Greenwald, D Phil (Oxon), Jack Lemons, PhD and John Kirkpatrick, MD, MS Surgeons should know how to alert the US FDA when an adverse event occurs with a device that has been approved by the FDA. Documentation […]
Evaluation of the Adult Patient (Aged >40 Years) With a Destructive Bone Lesion
Kristy L. Weber, MD J Am Acad Orthop Surg 2010 18 More than one half of cancer patients are likely to develop bone metastasis; thus, most orthopaedic surgeons will be presented with an adult patient with a destructive bone lesion. Proper management requires comprehensive patient evaluation, including history, physical examination, laboratory studies, and radiographic staging. […]
Antifibrinolytics in Major Orthopaedic Surgery
Jason David Eubanks, MD J Am Acad Orthop Surg 2010 18 Total joint arthroplasty and deformity surgery of the spine can require complex reconstructive procedures accompanied by the potential for major blood loss. In an attempt to minimize the perioperative blood loss associated with these procedures, recent focus has concentrated on the efficacy of pharmacologic […]
Ewing Sarcoma Family of Tumors
NULL J Am Acad Orthop Surg, Vol 18, No 2, February 2010 Aditya V. Maheshwari, MD and Edward Y. Cheng, MD The Ewing sarcoma family of tumors (ESFT) consists of a group of tumors characterized by morphologically similar round-cell neoplasm and by the presence of a common chromosomal translocation. Although rare, such tumors constitute the […]